BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

Size: px
Start display at page:

Download "BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )"

Transcription

1 BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year ) Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis and organization of bacterial cell (spore, flagelum, capsule, cell wall). Pathogenicity and virulence. Normal bacterial flora (colonization, primary sterile regions, composition and significance of normal flora). Carrier state and bacterial infection Bacterial metabolism; nutrition requirements for growth and replication of bacteria. Sterilization, control of sterilization, disinfection. Practical lesson 2 lessons Specimen collection (examination of specimen from different organ systems). Specimen transport (package and labeling) Bacterial genetic material; genetic exchange in bacteria: transformation, conjugation and transduction. Practical lesson 2 lessons Microscopic examination of morphological and structural components of bacterial cell (wet mounts, Metylene blue stain, Gram stain) Virulence factor of bacteria (adhesive factors, invasive factors, toxins). + Methods for bacterial isolation and identification Mechanism of action of antibacterial agents. Bacterial resistance to antibacterial agents. Antimicrobial susceptibility testing (disc diffusion method, broth dillution method and E test). 1

2 Microorganisms and their products in food, water and enviroment; diseases caused by these microorganisms. General properties of genus Streptococcus, characteristics and medical imortance of Streptococcus pyogenes. Methods for rapid diagnosis of bacterial infections. Serologic tests in diagnosis of bacterial infections Properties and medical imortance of Streptococcus pneumoniae, Streptococcus agalactiae and viridans streptococci. General properties and medical importance of genus Enterococcus. General properties of genus Neisseria; characteristics and medical imortance of Neisseria gonorrhoeae and Neisseria meningitidis Laboratory diagnosis of infections caused by genus Streptococcus and genus Enterococcus General properties of genus Staphylococcus; characteristics and medical imortance of Staphylococcus aureus; properties and medical imortance of coagulase negative staphylococci (Staphylococcus epidermidis, Staphylococcus saprophyticus) and biofim production. Laboratory diagnosis of infections caused by genus Staphylococcus and genus Neisseria General properties of familly Enterobacteriacea; characteristics and medical imortance of opportunistic enterobacteria (Enterobacter, Klebsiella, Serratia, Proteus), characteristics and medical imortance of genus Yersinia and species Yersinia enterocolitica. Characteristics and medical imortance of Escherichia coli. Characteristics and medical imortance of genus Salmonella and genus Shigella. General properties and medical imortance genus Corynebacterium; characteristics and medical imortance of Corynebacterium diphtheriae and diphtheroids. 2

3 General properties of genus Mycobacterium; characteristics and medical imortance of Mycobacterium tuberculosis complex; characteristics and medical imortance of Mycobacterium leprae and opportunistics mycobacteria. Laboratory diagnosis of infections caused by enterobacteria General properties and medical imortance of Gram negative nonfermentative bacteria; characteristics and medical imortance of Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia. General properties and medical imortance of asporogenic anaerobic bacteria; characteristics and medical imortance of genus Bacteroides and genus Propionibacterium. Laboratory diagnosis of infections caused by genus Mycobacterium General properties of genus Clostridium; characteristics and medical imortance of Clostridium difficile, Clostridium perfringens and other causative agents of clostridial mionecrosis. General properties and medical imortance of Clostridium tetani and Clostridium botulinum. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by Gram negative nonfermentative bacteria. General properties and medical imortance of Listeria monocytogenes General properties and medical imortance of genus Chlamydia, Chlamydophila, Mycoplasma, Ureaplasma. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by anaerobic sporeforming and non-sporeforming bacteria. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by strictly intracellular bacteria and mycoplasma. 3

4 Medical importance of zoonotic bacteria, general properties and medical imortance of genus Brucella and genus Francisella. General properties and medical imortance of genus Rickettsia, Bartonella, Erhlichia, and bacteria Coxiella burnetii. General properties and medical imortance of genus Bacillus; characteristics and medical imortance of Bacillus anthracis i Bacillus cereus. General properties and medical imortance of Yersinia pestis General properties and medical imortance of Haemophilus influenzae and Bordetella pertussis General properties and medical imortance of Legionella pneumophila, Campylobacter jejuni and Helicobacter pylori. BACTERIOLOGY IV semester General properties and medical imortance of spirochetes, characteristics and medical imortance of Borrelia burgdorferi and Leptospira interrogans. Characteristics and medical imortance of Treponema pallidum General properties and medical imortance of Vibrio, characteristics and medical imortance of Vibrio cholerae. Bacterial vaccines. 4

5 Aktuelni bakterijski patogeni I: multirezistentni sojevi bakterija (MRSA, VRE, multirezistentne enterične bakterije, multirezistentne Gram negativne nefermentujuće bakterije, multirezistentni i ekstenzivno rezistentni Mycobacterium tuberculosis). Aktuelni bakterijski patogeni II: oportunističke bakterije (koagulaza negativne stafilokoke, Clostridium difficile, netuberkulozne mikobakterije, Rhodococcus equi i druge). Microbiology Course Director Professor Maja Ćupić 5

6 Important informations and rules on subject: MICROBIOLOGY 2 nd Academic year 2012/13 Course in Microbiology consists of three teaching areas: Bacteriology, Virology and Parasitology with Mycology. Class attendance is obliged, and only in the term schedule. This allows for a maximum of 2 absences from seminars / exercises without compensation per semester, but in summer semester absences must be from different areas. The final MARK from subject Microbiology is formed as follows: 30% of pre-exam assessment activities (colloquiums and evaluation activities) 20% practical exam grades 50% final test Pre-Exam Activities include taking colloquiums and evaluation of students' activities during school hours. Each colloquiums in the final evaluation carry maximum 20%, and student activities from a maximum of 10%. Colloquiums During the school year, there are two colloquiums: the end of the winter semester - Microbiology I and second at the end of the summer semester colloquium- Microbiology II. The maximum number of points that a student can win the Colloquium I was 35, and also the 35th Colloquium II. For each test shall be organized into two terms. Obliged to go out in the first period, while the second output only students who have failed the test in the first term and those who receive the approval of the Department on the basis of medical justification for the absence of the first term tests. Passed the colloquium where students achieve at least 51% of the maximum number of points. Failed the colloquium (0-50% points) does not carry points in the final rating and is calculated as 0. To exit the practical and final examination the student is NOT required to have passed a preliminary exams (regardless of the obligation on them to come). Passed the test is valid for 2 academic years. EVALUATION ACTIVITIES student during school carries so reward points. The maximum number of points in this way they can win is 35 as follows: Area points: Bacteriology 17 Virology 9 Parasitology with Mycology 9 TOTAL 35

7 Therefore, the total number of points with pre-exam activities that can achieve the maximum is 105, and the students who thus win 85 or more points, RELEASE the practical part of the examination in the academic year in which they listen to classes. Thus passed the skill test carries a maximum of 20% of the final grade. PRACTICAL exam are taken in the form of a CONVERSATION. Passed the practical exam, except for a period in which the pass is valid even following the exams (a total of three test periods). MARK ON FINAL TEST in MICROBIOLOGY II Academy year 2011/12 Total number of questions/points on Final Test in Microbiology are 100: 50 Bacteriology 26 Virology 24 Parasitology with Micology Half from total number of points 51 is needed for passing. It is neccessary to have minimum points from each fields: 25 from Bacteriology 13 from Virology 13 from Parasitology with Micology (six) (seven) (eigh) (nine) (ten) Final Mark represents SUM of SCORE/MARK from Pre-Exam Activities (Colloquiums and Students activities), Practical Exam and Final Test Microbiology Course Director Professor Maja Ćupić

KOMAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (KUST) Medical Bacteriology Syllabus (Theory) Spring 2016

KOMAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (KUST) Medical Bacteriology Syllabus (Theory) Spring 2016 Course Title Medical Bacteriology Syllabus (Theory) Spring 2016 Medical Bacteriology Course Code MLS3330 No. of Credits Department Medical Laboratory Science (MLS) College Science Pre-requisites Course

More information

MICROBIOLOGY BACTERIOLOGY III semester

MICROBIOLOGY BACTERIOLOGY III semester MICROBIOLOGY 2016-17 BACTERIOLOGY III semester 07. 10. 2016. Introduction in microbiology, bacterial taxonomy, general bacterial properties. Bacterial structures (capsule, cell wall). Pathogenicity and

More information

Department of Microbiology, IMS, BHU Teaching schedule B.D.S. 4 th Semester 2 nd Year (2017 Batch) Session

Department of Microbiology, IMS, BHU Teaching schedule B.D.S. 4 th Semester 2 nd Year (2017 Batch) Session Department of Microbiology, IMS, BHU Teaching schedule B.D.S. 4 th Semester 2 nd Year (2017 Batch) 2018-19 Session Date Topic Name of Faculty members/ Senior Resident* 02.01.2019 Viridans group of Streptococci

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 39, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 49, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 38, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 33, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 22, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 50, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 3, 2019 (Notification

More information

STUDY PLAN II year students 2nd semester 1 Class

STUDY PLAN II year students 2nd semester 1 Class STUDY PLAN II year students 2nd semester 1 Class 1. Pyogenic cocci. Staphylococcus aureus, staphylococcus species, differentiation of staphylococci. Pathogenicity factors and toxins. Characteristics of

More information

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE THE KENYA POLYTECHNIC UNIVERSITY COLLEGE SCHOOL OF HEALTH SCIENCES AND TECHNOLOGY DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCES AND TECHNOLOGY DIPLOMA IN MEDICAL LABORATORY SCIENCES FINAL YEAR EXAMINATION

More information

Selected New Jersey Communicable Disease Regulations

Selected New Jersey Communicable Disease Regulations COMMUNICABLE DISEASE OUTBREAK MANUAL New Jersey s Public Health Response Selected New Jersey Communicable Disease Regulations June 2013 Public Health Emergency Response Capability Requirements as stated

More information

Fort Detrick Area B11 Removal Action Update

Fort Detrick Area B11 Removal Action Update Area B11 Removal Action Update US Army Corps Restoration Advisory Board Meeting 13 February 2002, 7:30 PM Frederick, Maryland Excavation of overburden material completed and clean soil moved to Area B

More information

Mechanisms of Pathogenicity

Mechanisms of Pathogenicity Mechanisms of Pathogenicity The Microbes Fight Back Medically important bacteria Salmonella Bacillus anthracis Shigella dysenteriae Campylobacter Shigella sonnei Clostridium botulinum Staphylococcus aureus

More information

INFECTIOUS DISEASE. Page 2

INFECTIOUS DISEASE. Page 2 Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic

More information

Microbiology EQA Product Portfolio

Microbiology EQA Product Portfolio Labquality EQAS Microbiology EQA Product Portfolio Clinically relevant external quality assessment program for microbiology Bacterial serology Bacteriology Mycology Parasitology Preanalytics Virology Labquality

More information

M O L E C U L A R G E N E T I C S

M O L E C U L A R G E N E T I C S MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are

More information

Potential Reimbursement CPT Codes

Potential Reimbursement CPT Codes BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may

More information

SUMMER SEMESTER/ II nd ACADEMIC YEAR BACTERIOLOGY 4th semester FRIDAY. MICROBIOLOGY Lecture (Head Building) 11:00-12:30

SUMMER SEMESTER/ II nd ACADEMIC YEAR BACTERIOLOGY 4th semester FRIDAY. MICROBIOLOGY Lecture (Head Building) 11:00-12:30 SUMMER SEMESTER/ II nd ACADEMIC YEAR BACTERIOLOGY 4th semester Lectures -Head Building, Friday 11:00-12:30 Seminars/Practical Lessons-Lab.Room Instutute of Microbiology and Immunology, Friday 13:00-15:30

More information

V. A. Bacterial Diseases

V. A. Bacterial Diseases V. A. Bacterial Diseases A. Airborne Bacterial Diseases B. Foodborne & Waterborne Bacterial Diseases C. Soilborne Bacterial Diseases D. Arthropodborne Bacterial Diseases E. Sexually Transmitted Bacterial

More information

Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish

Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish No. 786/1986 Communicable Diseases Decree Issued on 31 October 1986 Section 1 was repealed

More information

Rapid and progressive necrosis of the tissue underlying epidermis (cellulitis)

Rapid and progressive necrosis of the tissue underlying epidermis (cellulitis) Table 1. Infections of the Skin, Eyes and Ears Folliculitis Furuncles (boils) & Carbuncles Staphylococcus aureus (G+) Scald Skin Syndrome Peeling skin on infants Staphylococcus aureus (G+) Impetigo Lesions

More information

CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014

CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014 TITLE 310. CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014 310:515-1-1. Purpose The rules in this Chapter implement the Communicable Diseases Reporting Regulations, 63 O.S. 1981,

More information

Bacterial Pathogenicity & Infections. Stijn van der Veen

Bacterial Pathogenicity & Infections. Stijn van der Veen Bacterial Pathogenicity & Infections Stijn van der Veen Pathogenicity & Infection Pathogenicity is the ability of a microbe to gain entry to the host s tissue and bring about a physiological or anatomical

More information

SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH

SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH HPH 102: MEDICAL MICROBIOLOGY DATE: 7/12/2015 TIME:10:30-12:30PM INSTRUCTIONS

More information

Section 1 has been repealed by Decree of 30 December 2003/1383.

Section 1 has been repealed by Decree of 30 December 2003/1383. Ministry of Social Affairs and Health, Finland Unofficial translation No. 786/1986 Communicable Diseases Decree Issued on 31 October 1986 Section 1 has been repealed by Decree of 30 December 2003/1383.

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease

More information

Environmental Monitoring, risk assessment and responsibilities

Environmental Monitoring, risk assessment and responsibilities Environmental Monitoring, risk assessment and responsibilities Medical Devices Directive -93/42/EEC ANNEX I ESSENTIAL REQUIREMENTS 8. Infection and microbial contamination 8.1. The devices and manufacturing

More information

FirstRanker.com. [KT 540] AUGUST 2008 Sub. Code : 4061

FirstRanker.com. [KT 540] AUGUST 2008 Sub. Code : 4061 [KT 540] AUGUST 2008 Sub. Code : 4061 Time : Three hours I. Essay Questions : (2 x 15 = 30) 1. Define and classify sterilization. Write about sterilization by moist heat. 2. Mention the bacterial agents

More information

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine Normal Human Flora (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine 2014-2015 Objectives Describe important human normal flora. Demonstrate the epidemiology of human normal flora. Determine

More information

Fiscal Note for Permanent Rule Changes for North Carolina Division of Public Health

Fiscal Note for Permanent Rule Changes for North Carolina Division of Public Health Fiscal Note for Permanent Rule Changes for North Carolina Division of Public Health Agency: Dept. Of Health and Human Services, Division of Public Health, Epidemiology Section, Communicable Disease Branch

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Cardiovascular Diseases. Dr. Hala Al- Daghistani

Cardiovascular Diseases. Dr. Hala Al- Daghistani Cardiovascular Diseases Dr. Hala Al- Daghistani Cardiovascular system (circulatory system), defined as a group of organs that transport blood, nutrients, and remove waste products it carries to and from

More information

The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System. Michael H. Kramer

The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System. Michael H. Kramer The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System VHPB - Meeting, Berlin, Germany, 13-14 October 2003 Michael H. Kramer Federal Ministry of

More information

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH Policy # MI/EDU/08/04/v01 Page1 of 13 Section: Subject Title: Resident Objectives at MSH Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director Revision Date: SPECIMENS

More information

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents Objectives Atypical Pneumonia K. Sue Kehl, Ph.D., D(ABMM) Associate Professor, Pathology Medical College of Wisconsin Associate Director of Clinical Pathology & Technical Director of Microbiology, Children's

More information

Microsan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC #

Microsan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC # : Contact Time: 30 seconds 17,500 ppm. PCMX active Organism Positives ATCC # Acinetobacter calcoaceticus var. anitratus 0 s Acinetobacter calcoaceticus var. woffii 0 s Actinobacillus pleuropneumonia 0

More information

Microbes as Agents of Infectious Disease

Microbes as Agents of Infectious Disease Microbes as Agents of Infectious Disease Normal Flora Virulence and Pathogenicity Toxicity vs. Invasiveness WE ARE NOT ALONE! We are outnumbered. The average human contains about 10 trillion cells. On

More information

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the

More information

Interstate Shipment of Etiologic Agents 42 CFR Part 72

Interstate Shipment of Etiologic Agents 42 CFR Part 72 Interstate Shipment of Etiologic Agents 42 CFR Part 72 Federal Register, Vol. 45, No. 141-Monday, July 21, 1980. Part 72-Interstate Shipment of Etiologic Agents 1 Centers for Disease Control and Prevention

More information

स क ष मज व ववज ञ न ववभ ग DEPARTMENT OF MICROBIOLOGY व.एम.एम.स ए व सफदरज ग अस पत ल VMMC & SAFDARJUNG HOSPITAL नई ददल ल ११००२९ NEW DELHI

स क ष मज व ववज ञ न ववभ ग DEPARTMENT OF MICROBIOLOGY व.एम.एम.स ए व सफदरज ग अस पत ल VMMC & SAFDARJUNG HOSPITAL नई ददल ल ११००२९ NEW DELHI स क ष मज व ववज ञ न ववभ ग DEPARTMENT OF MICROBIOLOGY व.एम.एम.स ए व सफदरज ग अस पत ल VMMC & SAFDARJUNG HOSPITAL नई ददल ल ११००२९ NEW DELHI 110029 Teaching Schedule for MBBS 4thSemester (January June 2017)

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

"Wanted Poster" Diseases

Wanted Poster Diseases "Wanted Poster" Diseases Part One - Choosing a Disease Listed below are several bacteria and the disease they cause. Pick any one bacteria/disease to research. It is highly recommended that you pick a

More information

List of teams: Practice question: Which of the following individuals was among the first to recognize the importance of handwashing?

List of teams: Practice question: Which of the following individuals was among the first to recognize the importance of handwashing? List of teams: 1. Group 1 - Room 304 - Dr. Dobkin 2. Group 2 - Room 306 - Dr. Yin 3. Group 3 - Room 308 - Dr. Lowy 4. Group 4 - Room 310 - Dr. Neu 5. Group 5 - Room 316 - Dr. Prince 6. Group 6 - Room 320

More information

SCOTT COUNTY DAY CARE PROVIDER POLICY

SCOTT COUNTY DAY CARE PROVIDER POLICY SCOTT COUNTY DAY CARE PROVIDER POLICY THIS CONTRACT MAY BE USED ALONE OR MUST BE ATTACHED TO YOUR OWN CONTRACT OR INCORPORATED INTO YOUR OWN CONTRACT [MN Rule 9502.0405, Subp. (3)] The provider shall have

More information

Amoxitid 125 Suspension Each teaspoonful (5 ml) contains Amoxicillin (as trihydrate) 125 mg.

Amoxitid 125 Suspension Each teaspoonful (5 ml) contains Amoxicillin (as trihydrate) 125 mg. AMOXITID Composition Amoxitid 250 Capsules Each capsule contains Amoxicillin (as trihydrate) 250 mg. Capsules & Suspension Amoxitid 500 Capsules Each capsule contains Amoxicillin (as trihydrate) 500 mg.

More information

CLINICAL MICROBIOLOGY AND IMMUNOLOGY. Microbial Mechanisms of Pathogenicity

CLINICAL MICROBIOLOGY AND IMMUNOLOGY. Microbial Mechanisms of Pathogenicity CLINICAL MICROBIOLOGY AND IMMUNOLOGY Microbial Mechanisms of Pathogenicity -Pathogenicity - ability of pathogen to cause disease by overcoming the defenses of the host -Virulence - degree of pathogenicity

More information

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p.

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p. Extract Vademecum Department of Medical Microbiology Status: Code: Version: Approval date: Geldig MMB-PR-04/1 1 Juni 2017 Name request Specimen Material needed Transport Bacteriology Bacterial culture

More information

MICROBIOLOGY - An Overview

MICROBIOLOGY - An Overview MICROBIOLOGY - An Overview Hieucam Phan, MD Pediatrics St. Luke s Hospital San Francisco, CA Microbiology 6/01 1 Introduction Major Achievements of Medical Sciences in the 20th Century Microbiology DNA

More information

Scheme Description. Clinical Microbiology Laboratory Scheme

Scheme Description. Clinical Microbiology Laboratory Scheme CLS Clinical Microbiology Laboratory Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0)

More information

TOUCAN DATA & SCIENCE INFORMATION

TOUCAN DATA & SCIENCE INFORMATION TOUCAN DATA & SCIENCE INFORMATION RESEARCH Centrego s Toucan ElectroChemical Activation (ECA) devices generate a powerful sanitizing and disinfecting solution containing hypochlorous acid, the same natural

More information

Division of Studies in English (2/6MD winter semester, 2017/2018) MICROBIOLOGY OUTLINE

Division of Studies in English (2/6MD winter semester, 2017/2018) MICROBIOLOGY OUTLINE C1. General microbiology bacteriological media, methods of the microbiological inoculation and cultivation, preparation of pure cultures, the structure of the bacterial cell, staining methods of the bacterial

More information

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. # Inc. Efficacy: Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic serum

More information

Microbes as Agents of Infectious Disease

Microbes as Agents of Infectious Disease Microbes as Agents of Infectious Disease Normal Flora Virulence and Pathogenicity Toxicity vs. Invasiveness WE ARE NOT ALONE! We are outnumbered. The average human contains about 10 trillion cells. On

More information

Veterinary Bacteriology and Mycology

Veterinary Bacteriology and Mycology Veterinary Bacteriology and Mycology PJL:2011 Bacterial Overview: Morphology, Structure, Jargon General Features Domain Bacteria Proteobacteria Spirochaetes Firmicutes Actinobacteria No nuclear membrane

More information

Microbiology Specimen Collection Instructions. Table I Culture and Sensitivities/TB

Microbiology Specimen Collection Instructions. Table I Culture and Sensitivities/TB Specimen Page 1 of 10 Source / Type of Specimen Culture and Sensitivities () Abscess aspirate, wound aspirate in sterile screw cap or swab in charcoal. Obtain anaerobic swab from lab. Pilonidal and perirectal

More information

Bio Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease

Bio Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease Bio 230 - Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease It has been calculated that the normal human houses about 10 12 bacteria on the skin, 10 10 in the mouth, and

More information

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized

More information

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory This appendix contains a list of agents that, when reasonably anticipated to be present, require a laboratory to comply

More information

Anaerobic bacteria and more. Stijn van der Veen

Anaerobic bacteria and more. Stijn van der Veen Anaerobic bacteria and more Stijn van der Veen Anaerobic bacteria Anaerobic bacteria do not require oxygen for growth. Some anaerobic bacteria die in the presence of oxygen, while others are able to tolerate

More information

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. # Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic

More information

Report on the Performance of the. VidaShield System

Report on the Performance of the. VidaShield System Report on the Performance of the VidaShield System By Dr. Wladyslaw J. Kowalski Prepared for Arcalux Corporation, 6306 Alder Drive, Houston, TX, 77081 Executive Summary The superior performance of the

More information

Burton's Microbiology for the Health Sciences

Burton's Microbiology for the Health Sciences Burton's Microbiology for the Health Sciences Section VII. Pathogenesis and Host Defense Mechanisms Burton's Microbiology for the Health Sciences Chapter 14. Pathogenesis of Infectious Diseases 1 Chapter

More information

Course Specification of Microbiology and Immunology for master of HepatobillarySurgery A- Administrative Information Course Title: Microbiology and

Course Specification of Microbiology and Immunology for master of HepatobillarySurgery A- Administrative Information Course Title: Microbiology and Course Specification of Microbiology and Immunology for master of HepatobillarySurgery A- Administrative Information Course Title: Microbiology and Immunology Code: SURG H76 Department giving the course:

More information

LIST OF QUESTIONS FOR MODULE 2 and 3 MEDICAL MICROBIOLOGY AND VIROLOGY

LIST OF QUESTIONS FOR MODULE 2 and 3 MEDICAL MICROBIOLOGY AND VIROLOGY LIST OF QUESTIONS FOR MODULE 2 and 3 MEDICAL MICROBIOLOGY AND VIROLOGY 1. General characteristics of piogenic cocci. 2. Staphylococcus, staphylococcus species, differentiation signs of staphylococci. Factor

More information

Work up of Respiratory & Wound Cultures:

Work up of Respiratory & Wound Cultures: Work up of Respiratory & Wound Cultures: Culture work up 2 Systematic approaches 1 Work up of Respiratory & Wound Cultures Resident flora Colonizing organisms Pathogens 2 Work up of Respiratory & Wound

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

A guide to pathogenic bacteria

A guide to pathogenic bacteria Pathogens Also known as: Pathogenic organisms Infectious agents Germs Biological agents that cause disease Groups of pathogens: Bacteria Viruses Fungi Parasites Opportunistic pathogen A biological agent

More information

PEACEHEALTH LABORATORIES

PEACEHEALTH LABORATORIES 360-414-2306 www.peacehealthlabs.org Critical Values Call List - Longview Critical values are reported per the criteria published below. Laboratory results meeting these criteria indicate potential life-threatening

More information

Infection Data: Form Updates

Infection Data: Form Updates Infection Data: Form Updates Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Why is infection data important?

More information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University

More information

Pathogen Matrix PATHOGEN CLAIM PPM (MG/L) / ORP TIME (MIN) DETAILS SOURCE

Pathogen Matrix PATHOGEN CLAIM PPM (MG/L) / ORP TIME (MIN) DETAILS SOURCE Pathogen Matrix PATHOGEN CLAIM PPM (MG/L) / ORP TIME (MIN) DETAILS SOURCE A. niger 90% At (0.166-0.246). 5 N/A http://aem.asm.org/cgi/ Acinetobacter baumannii Reached 25 20 ozone gas http://www.tersano.com/pdf/ajic_

More information

Syndromic Testing: The right test, the first time.

Syndromic Testing: The right test, the first time. Syndromic Testing: The right test, the first time. Don t guess. Know. Infectious disease diagnostics has evolved. BioFire s syndromic approach is making the world a healthier place. Many infectious diseases

More information

Block DRAFT 17 (Revised )

Block DRAFT 17 (Revised ) Block 3 2019 DRAFT 17 (Revised 03.19.2018) April 1, 2019 May 24, 2019 8 Weeks 35 Class days 128.5 morning hours + 34.75 afternoon hours = 163.25 total hours 5 Quiz days (33 max total questions per quiz;

More information

4. The most common cause of traveller s diarrheoa is a. Rotavirus b. E coli c. Shigella d. Giardia e. Salmonella

4. The most common cause of traveller s diarrheoa is a. Rotavirus b. E coli c. Shigella d. Giardia e. Salmonella INFECTIOUS DISEASE 1. Mumps virus is a a. Adenovirus b. Herpes virus c. Paramyxovirus d. Pox virus e. Picornavirus 2. All of the following cause a clinical effect via the production of exotoxin except

More information

PATHOGEN DETECTION WITH THE FILMARRAY

PATHOGEN DETECTION WITH THE FILMARRAY PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into

More information

New Mexico Emerging Infections Program Overview. Joan Baumbach NM Department of Health September 23, 2016

New Mexico Emerging Infections Program Overview. Joan Baumbach NM Department of Health September 23, 2016 New Mexico Emerging Infections Program Overview Joan Baumbach NM Department of Health September 23, 2016 Emerging Infections Program History Established in 1995 as population-based, scientific, public

More information

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23 MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23 Chapter 21 I. MICROBIAL DISEASES OF THE SKIN A. Defense 1. Keratin 2. Sweat ducts 3. Oil glands

More information

Publications of the National Public Health Institute KTL B 10/2001. Infectious diseases in Finland 2000

Publications of the National Public Health Institute KTL B 10/2001. Infectious diseases in Finland 2000 Publications of the National Public Health Institute KTL B 10/2001 Infectious diseases in Finland 2000 Contributors Hiltunen-Back, Eija Kuusi, Markku Lyytikäinen, Outi Nuorti, Pekka Ruutu, Petri Siikamäki,

More information

Beta-lactamase production should have no effect on Azithromycin activity.

Beta-lactamase production should have no effect on Azithromycin activity. AZIMEX Composition Azimex 250 Capsules Each capsule contains Azithromycin (as dihydrate) 250 mg Capsules Azimex 500 mg Capsules Each capsule contains Azithromycin (as dihydrate) 500 mg Action Azithromycin

More information

Notes from the Sentinel Liaison

Notes from the Sentinel Liaison ADPH Unplugged Notes from the Sentinel Liaison Thank you for participating! Survey ListServ Notes Trainings Sentinel Training August 9-10, 2017 Packaging and Shipping September 14,2017 You can be a Sentinel

More information

MICROBIOLOGY , III semester BACTERIOLOGY

MICROBIOLOGY , III semester BACTERIOLOGY MICROBIOLOGY 2017-18, III semester BACTERIOLOGY 06. 10. 2017. prof. dr Branislava Savić Lecture 2 lessons Introduction in microbiology, bacterial taxonomy, general bacterial properties. Bacterial structures

More information

Consultation on the Revision of Carbapenem Breakpoints

Consultation on the Revision of Carbapenem Breakpoints Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints

More information

35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough

35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough The following are a list by department of Critical (Panic) Values: CHEMISTRY TEST LESS THAN GREATER THAN UNITS Glucose 0-7days 40 200 mg/dl Glucose > 7 days 50 400 mg/dl Glucose, CSF 25 mg/dl Sodium 121

More information

MEASLES MUMPS PERTUSSIS HEPATITIS A HEPATITIS B HEPATITIS C HAEMOPHILUS INFLUENZAE (INVASIVE DISEASE)...

MEASLES MUMPS PERTUSSIS HEPATITIS A HEPATITIS B HEPATITIS C HAEMOPHILUS INFLUENZAE (INVASIVE DISEASE)... TABLE OF CONTENTS LIST OF TABLES 1 ONE... 4 LIST OF FIGURES 2 TWO... 6 INTRODUCTION 3 THREE... 9 LIST OF REPORTABLE DISEASES AND CONDITIONS IN TENNESSEE, 2015... 13 VACCINE PREVENTABLE DISEASES 4 FOUR...

More information

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336

More information

MICROBE FLORA AND ORAL MICRIFLORAS. Prof. Dr. Tamer ŞANLIDAĞ

MICROBE FLORA AND ORAL MICRIFLORAS. Prof. Dr. Tamer ŞANLIDAĞ MICROBE FLORA AND ORAL MICRIFLORAS Prof. Dr. Tamer ŞANLIDAĞ People,animal and plats continuesly contact with micr0rorganism People; skin, Natural gaps, Organs contact with outsite, Sometimes disease can

More information

Beta-lactamase production should have no effect on Azithromycin activity.

Beta-lactamase production should have no effect on Azithromycin activity. AZIMEX Composition Azimex 250 Capsules Each capsule contains Azithromycin (as dihydrate) 250 mg Capsules & Powder Azimex 500 mg Capsules Each capsule contains Azithromycin (as dihydrate) 500 mg Azimex

More information

DEMIS Deutsches elektronisches Meldesystem für den Infektionsschutz (German electronic reporting system for infectious diseases control)

DEMIS Deutsches elektronisches Meldesystem für den Infektionsschutz (German electronic reporting system for infectious diseases control) DEMIS Deutsches elektronisches Meldesystem für den Infektionsschutz (German electronic reporting system for infectious diseases control) Project overview at Aware Machine 2 Machine Communication Dagstuhl,

More information

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05 Date company submitted: 15 Dec 04 Date received by CDER: 15 Dec 04 Reviewer: Fred Marsik, Ph.D. Date assigned: 15 Dec 04 NAME AND ADDRESS OF APPLICANT Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia,

More information

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection) COMPOSITION Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection) CEFTOMAX - S Injection 1.5 gm Each vial contains: Cefoperazone Sodium equivalent to Cefoperazone IP. 1,000 mg Sulbactam Sodium

More information

Class 15. Infections of the Central Nervous System

Class 15. Infections of the Central Nervous System English Division 6 E.D. Class 15 Infections of the Central Nervous System Pathogenesis, etiologic agents, clinical symptoms, and laboratory diagnosis To be performed: - Read carefully attached case studies

More information

1. Which of the following statements concerning Plasmodium vivax is TRUE?

1. Which of the following statements concerning Plasmodium vivax is TRUE? 1 Microm 301 Final Exam 2012 Practice Questions and Key 1. Which of the following statements concerning Plasmodium vivax is TRUE? A. It infects all stages of erythrocytes (immature, mature, and senescent).

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Microbiology 2017 MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Evaluation Criteria... 2 Microbiology

More information

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE AQUAOX IS A REVOLUTIONARY DISINFECTION SOLUTION WHICH ACTIVE INGREDIENT HOCL IS NON HAZARDOUS, HAS NO FRAGRANCE, AND IS SAFE ON ALL SURFACES (AND ON SKIN.) HYPOCHLOROUS ACID (HOCl) Our Body's immune system

More information

Lecture 3. Microbial Physiology

Lecture 3. Microbial Physiology Micro-Biology For 3 rd Sem. Students of ISM-IUK, Bishkek Lecture 3 Microbial Physiology LECTURE OBJECTIVES 1. Bacterial Growth 2. Growth Requirements 3. Nutritional types of microorganisms 4. Enzymes,

More information

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis Key words Sample Cell counting (EtBr) DNA extraction Cell-lysis by 3% SDS beads beating Before cell-lysis After cell-lysis Cell-lysis efficiency (Maintained70%) PCR PCR amplification of partial fragments

More information

Streptococci facultative anaerobe

Streptococci facultative anaerobe THE GENUS STREPTOCOCCUS The genus Streptococcus obtains Gram-positive cocci, nonmotile, nonsporeforming, arranged mostly in chains or in pairs. Most species are facultative anaerobes. Some of streptococci

More information

Pathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services

Pathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services Pathogen Reduction/Inactivation KABB Annual Meeting 2017 Elpidio Pena, MD, MA Norton Healthcare Transfusion Services Goals Discuss the approved methods for pathogen reduction/inactivation of blood products

More information